FDA
Public Health Product Hops
Are there circumstances for which allowing a product hop resulted in a net benefit to society that exceeded the excess costs associated with the new product?
Public Health Product Hops
Author
Michael S. Sinha
-
-
Health Law Policy
Monthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Monthly Round-Up of What to Read on Pharma Law and Policy
-
Health Law Policy
Monthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Monthly Round-Up of What to Read on Pharma Law and Policy
-
Health Law Policy
What to Read on Pharma Law and Policy this Month
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
What to Read on Pharma Law and Policy this Month
-
Health Law Policy
Monthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Monthly Round-Up of What to Read on Pharma Law and Policy
-
Health Law Policy
Roundup: What to Read in Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Roundup: What to Read in Pharma Law and Policy
-
Health Law Policy
Monthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Monthly Round-Up of What to Read on Pharma Law and Policy
-
Health Law Policy
Monthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Monthly Round-Up of What to Read on Pharma Law and Policy
-
Health Law Policy
Monthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Monthly Round-Up of What to Read on Pharma Law and Policy
-
Health Law Policy
Monthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health…
Monthly Round-Up of What to Read on Pharma Law and Policy